2017
Progress in the Treatment of Hodgkin’s Lymphoma
Longo DL, DeVita VT. Progress in the Treatment of Hodgkin’s Lymphoma. New England Journal Of Medicine 2017, 378: 392-394. PMID: 29224505, DOI: 10.1056/nejme1715141.Peer-Reviewed Original Research
2016
Vincent T. DeVita on His New Book, "The Death of Cancer," and the Current State of Cancer Care.
DeVita V. Vincent T. DeVita on His New Book, "The Death of Cancer," and the Current State of Cancer Care. Oncology 2016, 30: 210. PMID: 26984212.Peer-Reviewed Original Research
2014
Clinical cancer research: the past, present and the future
DeVita VT, Eggermont AM, Hellman S, Kerr DJ. Clinical cancer research: the past, present and the future. Nature Reviews Clinical Oncology 2014, 11: 663-669. PMID: 25245981, DOI: 10.1038/nrclinonc.2014.153.Peer-Reviewed Original ResearchTreatment of Hodgkin Lymphoma: A 50-Year Perspective
Canellos GP, Rosenberg SA, Friedberg JW, Lister TA, DeVita VT. Treatment of Hodgkin Lymphoma: A 50-Year Perspective. Journal Of Clinical Oncology 2014, 32: 163-168. PMID: 24441526, DOI: 10.1200/jco.2013.53.1194.Peer-Reviewed Original ResearchAntineoplastic Combined Chemotherapy ProtocolsBiomarkers, TumorBleomycinClinical Trials as TopicCyclophosphamideDacarbazineDisease-Free SurvivalDoxorubicinEtoposideEuropeHistory, 20th CenturyHodgkin DiseaseHumansMechlorethamineNeoplasm StagingPositron-Emission TomographyPrednisoneProcarbazineSurvival RateTomography, X-Ray ComputedTreatment OutcomeVinblastineVincristine
2010
Focus issue on biomarkers
Hutchinson L, DeVita V. Focus issue on biomarkers. Nature Reviews Clinical Oncology 2010, 7: 295-295. PMID: 20517335, DOI: 10.1038/nrclinonc.2010.70.Peer-Reviewed Original ResearchA breakthrough in Hodgkin's disease
DeVita V. A breakthrough in Hodgkin's disease. Nature Reviews Clinical Oncology 2010, 7: 179-179. PMID: 20354537, DOI: 10.1038/nrclinonc.2010.36.Peer-Reviewed Original ResearchBreast cancer screening and mortality
DeVita V. Breast cancer screening and mortality. Nature Reviews Clinical Oncology 2010, 7: 65-65. PMID: 20118972, DOI: 10.1038/nrclinonc.2009.232.Peer-Reviewed Original Research
2009
We have met the enemy and he is us!
DeVita V. We have met the enemy and he is us! Nature Reviews Clinical Oncology 2009, 6: 493-493. PMID: 19707237, DOI: 10.1038/nrclinonc.2009.89.Peer-Reviewed Original ResearchThe most important news at ASCO 2009
DeVita V. The most important news at ASCO 2009. Nature Reviews Clinical Oncology 2009, 6: 371-371. PMID: 19561629, DOI: 10.1038/nrclinonc.2009.93.Peer-Reviewed Original ResearchOff-label use of approved drugs
DeVita V. Off-label use of approved drugs. Nature Reviews Clinical Oncology 2009, 6: 181-181. PMID: 19333219, DOI: 10.1038/nrclinonc.2009.41.Peer-Reviewed Original ResearchNews the public should rely on
DeVita V. News the public should rely on. Nature Reviews Clinical Oncology 2009, 6: 59-59. PMID: 19180108, DOI: 10.1038/ncponc1301.Peer-Reviewed Original Research
2008
The clinical trials system is broken
DeVita V. The clinical trials system is broken. Nature Reviews Clinical Oncology 2008, 5: 683-683. PMID: 19034294, DOI: 10.1038/ncponc1263.Peer-Reviewed Original ResearchThe era of personalized medicine: back to basics
Hutchinson L, DeVita V. The era of personalized medicine: back to basics. Nature Reviews Clinical Oncology 2008, 5: 623-623. PMID: 18957968, DOI: 10.1038/ncponc1253.Peer-Reviewed Original ResearchAntibodies, MonoclonalAntibodies, Monoclonal, HumanizedAntineoplastic AgentsAntineoplastic Combined Chemotherapy ProtocolsBenzamidesBiomarkers, TumorCarcinoma, Non-Small-Cell LungCetuximabClinical Trials as TopicColorectal NeoplasmsDrug Delivery SystemsDrug Resistance, NeoplasmGene TargetingGenes, erbB-1HumansImatinib MesylateLeukemia, Myelogenous, Chronic, BCR-ABL PositiveLung NeoplasmsPanitumumabPatient-Centered CarePiperazinesPyrimidinesTreatment OutcomeMore on strong inference
DeVita V. More on strong inference. Nature Reviews Clinical Oncology 2008, 5: 239-239. PMID: 18437157, DOI: 10.1038/ncponc1126.Peer-Reviewed Original ResearchStrong inference
DeVita V. Strong inference. Nature Reviews Clinical Oncology 2008, 5: 177-177. PMID: 18376422, DOI: 10.1038/ncponc1094.Peer-Reviewed Original ResearchHealth insurance reform—beware of the general solution for the specific problem
DeVita V. Health insurance reform—beware of the general solution for the specific problem. Nature Reviews Clinical Oncology 2008, 5: 59-59. PMID: 18235439, DOI: 10.1038/ncponc1046.Peer-Reviewed Original ResearchConceptsGeneral solution
2007
The Provenge® decision
DeVita V. The Provenge® decision. Nature Reviews Clinical Oncology 2007, 4: 381-381. PMID: 17554239, DOI: 10.1038/ncponc0854.Peer-Reviewed Original Research
2006
A step in the right direction
DeVita V. A step in the right direction. Nature Reviews Clinical Oncology 2006, 3: 641-641. PMID: 17139311, DOI: 10.1038/ncponc0669.Peer-Reviewed Original ResearchLet's return to the “belly bath”
DeVita V. Let's return to the “belly bath”. Nature Reviews Clinical Oncology 2006, 3: 405-405. PMID: 16894365, DOI: 10.1038/ncponc0568.Peer-Reviewed Original ResearchThe concept of cure
DeVita V. The concept of cure. Nature Reviews Clinical Oncology 2006, 3: 59-59. PMID: 16462824, DOI: 10.1038/ncponc0422.Peer-Reviewed Original Research